眼科研究
眼科研究
안과연구
CHINESE OPHTHALMIC RESEARCH
2009年
11期
950-954
,共5页
刘丹岩%马景学%安建斌%王萌
劉丹巖%馬景學%安建斌%王萌
류단암%마경학%안건빈%왕맹
苦参碱%聚乳酸%微球%增生性玻璃体视网膜病变
苦參堿%聚乳痠%微毬%增生性玻璃體視網膜病變
고삼감%취유산%미구%증생성파리체시망막병변
matrine%polyactic acid%microsphere%proliferative vitreoretinopathy
目的 评价苦参碱聚乳酸微球防治实验性增生性玻璃体视网膜病变(PVR)的效果.方法 30只新西兰白兔玻璃体腔注入成纤维细胞悬液制备PVR模型.随机分为3组,玻璃体腔分别注入载药微球(含苦参碱4mg)、游离苦参碱(2mg)、生理盐水和空白聚乳酸微球.玻璃体腔手术操作后第1、3、7、14、21、28、35天观察眼前节炎症反应情况、玻璃体混浊程度、玻璃体腔内微球分解过程、玻璃体内增生情况及视网膜是否脱离以及脱离的程度.结果 所有动物1周内前房有轻~中度的炎症反应,1周后消失.各组均有不同比例的动物在不同时间点发展为PVR Ⅰ~Ⅲ级.视网膜脱离的发生率:游离药物组与对照组比较,除35d外,其余各时间点差异均有统计学意义(P<0.05);载药微球组与对照组相比,各时间点差异均有统计学意义(P<0.05);载药微球组与游离药物组比较,28d和35d时差异均有统计学意义(P<0.05).结论 苦参碱聚乳酸微球兔眼玻璃体腔注射能够有效防治实验性PVR.
目的 評價苦參堿聚乳痠微毬防治實驗性增生性玻璃體視網膜病變(PVR)的效果.方法 30隻新西蘭白兔玻璃體腔註入成纖維細胞懸液製備PVR模型.隨機分為3組,玻璃體腔分彆註入載藥微毬(含苦參堿4mg)、遊離苦參堿(2mg)、生理鹽水和空白聚乳痠微毬.玻璃體腔手術操作後第1、3、7、14、21、28、35天觀察眼前節炎癥反應情況、玻璃體混濁程度、玻璃體腔內微毬分解過程、玻璃體內增生情況及視網膜是否脫離以及脫離的程度.結果 所有動物1週內前房有輕~中度的炎癥反應,1週後消失.各組均有不同比例的動物在不同時間點髮展為PVR Ⅰ~Ⅲ級.視網膜脫離的髮生率:遊離藥物組與對照組比較,除35d外,其餘各時間點差異均有統計學意義(P<0.05);載藥微毬組與對照組相比,各時間點差異均有統計學意義(P<0.05);載藥微毬組與遊離藥物組比較,28d和35d時差異均有統計學意義(P<0.05).結論 苦參堿聚乳痠微毬兔眼玻璃體腔註射能夠有效防治實驗性PVR.
목적 평개고삼감취유산미구방치실험성증생성파리체시망막병변(PVR)적효과.방법 30지신서란백토파리체강주입성섬유세포현액제비PVR모형.수궤분위3조,파리체강분별주입재약미구(함고삼감4mg)、유리고삼감(2mg)、생리염수화공백취유산미구.파리체강수술조작후제1、3、7、14、21、28、35천관찰안전절염증반응정황、파리체혼탁정도、파리체강내미구분해과정、파리체내증생정황급시망막시부탈리이급탈리적정도.결과 소유동물1주내전방유경~중도적염증반응,1주후소실.각조균유불동비례적동물재불동시간점발전위PVR Ⅰ~Ⅲ급.시망막탈리적발생솔:유리약물조여대조조비교,제35d외,기여각시간점차이균유통계학의의(P<0.05);재약미구조여대조조상비,각시간점차이균유통계학의의(P<0.05);재약미구조여유리약물조비교,28d화35d시차이균유통계학의의(P<0.05).결론 고삼감취유산미구토안파리체강주사능구유효방치실험성PVR.
Objective To establish a matrine delivery system in vitreous is very important for the dynamic treatment of proliferative vitreoretinopathy(PVR) . Present study was to evaluate the efficacy of matrine polyactic acid microsphere(MAT-PLA-MS) in prevention of PVR. Methods The suspension of cultured fibroblasts was injected into vitreous cavity of 30 healthy adult New Zealand albino rabbits to induce PVR. Then the experimental rabbits were divided into 3 groups and 10 rabbits for each. The animals received intravitreal injection of 0.3 mL MAT-PLA-MS(4 mg) matrine in MAT-PLA-MS group. Free matrine normal sodium solution 0.3 mL(containing 2mg matrine) was injected in vitreous cavity in free matrine group. 0. 3 mL normal saline solution was injected into the vitreous of the left eyes and the equivalent volume of blank polyaetic acid microsphere(blank-PLA-MS) into the right eyes in control group. The changes of cornea, aqueous humor, lens, vitreous and fundus were examined and recorded by slit lamp biomicroscope, indirect ophthalmoscope, fundus color camera and B ultrasonogram on the 1st, 3rd, 7th, 14th, 21st, 28th and 35th day following injection of drug. The inhibition effect of matrine on PVR was evaluated according to Ryan' s grading criteria of PVR. Results On the 14th days after implantation of MAT-PLA-MS, the rate of retinal detachment was 60%, 10%, 5% and 60% in normal saline group, free matrine group, MAT-PLA-MS group and blank-PLA-MS group respectively. Statistically significant difference was found among normal saline group, blank-PLA-MS group, MAT-PLA-MS group and free matrine group(P <0. 05). On the 21st day after injection of fibroblasts, the morbidity of retinal detachment was 80%, 30%, 10% and 80% in normal saline group, free matrine group, MAT-PLA-MS group and blank-PLA-MS group respectively, showing a significant difference among different groups. On the 28th day, the incidence rate of retinal detachment was 90%, 50%, 15% and 90% respectively, presenting statistical difference among various groups (P < 0. 05) as well as between free matrine group and MAT-PLA-MS group (P<0. 05). On the 35th day, considerably difference also was seen in the morbidity of retinal detachment among various groups (90%, 60%, 15% and 90% respectively) (P<0.05). Conclusion Implantation of MAT-PLA-M S into vitreous cavity can effectively inhibit the development of PVR induced by fibroblasts in rabbit model.